Comparison of a New Automated Ventilatory Mode Named Intellivent to Standard Controlled Ventilation in Brain Injured Patients
NCT ID: NCT01695603
Last Updated: 2017-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2012-03-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Controlled MAP in the Brain Injury Patient (COMAT Study)
NCT03991052
Characterizing the cerebrovAscular Physiology of Optimal Mean Arterial Pressure Targeted Resuscitation
NCT03609333
Impact of Continuous Monitoring of PtC02 on Ventilatory Weaning in Neuro-injured Patients
NCT04819984
Intensive Monitoring of Brain Injured Patients
NCT00163774
Delineating Between Pathophysiologic Phenotypes of Hypoxic Ischemic Brain Injury After Cardiac Arrest
NCT05390060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard mode of controlled ventilation
Each brain injured patient will be ventilated during two hours with a standard mode of controlled ventilation.
No interventions assigned to this group
Intellivent arm
Each brain injured patient will be ventilated during two hours with an automated mode of ventilation, the Intellivent mode.
Intellivent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intellivent
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Glasgow coma scale of 9 or less
* Controlled mechanical ventilation required
* Intracranial pressure monitoring required for clinical reasons
Exclusion Criteria
* clinical signs of brainstem lesions
* patients with withdrawal order or for whom organ donation is under discussion
* major haemodynamic instability
* High carbon dioxide alveoloarterial gradient (\>10 mmHg) and/or suffering of severe hypoxemia (PaO2/FIO2 \< 150 mmHg)
* Patients included in another interventional clinical study
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lausanne Hospitals
OTHER
Prof. Philippe Jolliet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Philippe Jolliet
Main investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe Jolliet, Prof
Role: PRINCIPAL_INVESTIGATOR
University of Lausanne Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Adult Intensive Care and Burn Unit, University hospital of Lausanne
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Intellibrain
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.